Efficacy, Safety Study and Benefit of Alkali Therapy in Sickle Cell Disease
NCT01894594
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
7
Enrollment
OTHER
Sponsor class
Stopped
Poor recruitment
Conditions
Sickle Cell Anemia
Chronic Kidney Disease
Metabolic Acidosis
Interventions
DRUG:
Sodium Bicarbonate
Sponsor
University Hospitals Cleveland Medical Center